233 related articles for article (PubMed ID: 31315928)
1. Cyclophilin A allows the allosteric regulation of a structural motif in the disordered domain 2 of NS5A and thereby fine-tunes HCV RNA replication.
Dujardin M; Madan V; Gandhi NS; Cantrelle FX; Launay H; Huvent I; Bartenschlager R; Lippens G; Hanoulle X
J Biol Chem; 2019 Aug; 294(35):13171-13185. PubMed ID: 31315928
[TBL] [Abstract][Full Text] [Related]
2. A Proline-Tryptophan Turn in the Intrinsically Disordered Domain 2 of NS5A Protein Is Essential for Hepatitis C Virus RNA Replication.
Dujardin M; Madan V; Montserret R; Ahuja P; Huvent I; Launay H; Leroy A; Bartenschlager R; Penin F; Lippens G; Hanoulle X
J Biol Chem; 2015 Jul; 290(31):19104-20. PubMed ID: 26085105
[TBL] [Abstract][Full Text] [Related]
3. Domain 3 of NS5A protein from the hepatitis C virus has intrinsic alpha-helical propensity and is a substrate of cyclophilin A.
Verdegem D; Badillo A; Wieruszeski JM; Landrieu I; Leroy A; Bartenschlager R; Penin F; Lippens G; Hanoulle X
J Biol Chem; 2011 Jun; 286(23):20441-54. PubMed ID: 21489988
[TBL] [Abstract][Full Text] [Related]
4. A conserved tandem cyclophilin-binding site in hepatitis C virus nonstructural protein 5A regulates Alisporivir susceptibility.
Grisé H; Frausto S; Logan T; Tang H
J Virol; 2012 May; 86(9):4811-22. PubMed ID: 22345441
[TBL] [Abstract][Full Text] [Related]
5. Interactions of the Disordered Domain II of Hepatitis C Virus NS5A with Cyclophilin A, NS5B, and Viral RNA Show Extensive Overlap.
Ngure M; Issur M; Shkriabai N; Liu HW; Cosa G; Kvaratskhelia M; Götte M
ACS Infect Dis; 2016 Nov; 2(11):839-851. PubMed ID: 27676132
[TBL] [Abstract][Full Text] [Related]
6. NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B.
Bessa LM; Launay H; Dujardin M; Cantrelle FX; Lippens G; Landrieu I; Schneider R; Hanoulle X
J Biol Chem; 2017 Nov; 292(44):18024-18043. PubMed ID: 28912275
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus NS5A protein is a substrate for the peptidyl-prolyl cis/trans isomerase activity of cyclophilins A and B.
Hanoulle X; Badillo A; Wieruszeski JM; Verdegem D; Landrieu I; Bartenschlager R; Penin F; Lippens G
J Biol Chem; 2009 May; 284(20):13589-13601. PubMed ID: 19297321
[TBL] [Abstract][Full Text] [Related]
8. Cyclophilin A interacts with domain II of hepatitis C virus NS5A and stimulates RNA binding in an isomerase-dependent manner.
Foster TL; Gallay P; Stonehouse NJ; Harris M
J Virol; 2011 Jul; 85(14):7460-4. PubMed ID: 21593166
[TBL] [Abstract][Full Text] [Related]
9. ISGylation of Hepatitis C Virus NS5A Protein Promotes Viral RNA Replication via Recruitment of Cyclophilin A.
Abe T; Minami N; Bawono RG; Matsui C; Deng L; Fukuhara T; Matsuura Y; Shoji I
J Virol; 2020 Sep; 94(20):. PubMed ID: 32727878
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus NS5B and host cyclophilin A share a common binding site on NS5A.
Rosnoblet C; Fritzinger B; Legrand D; Launay H; Wieruszeski JM; Lippens G; Hanoulle X
J Biol Chem; 2012 Dec; 287(53):44249-60. PubMed ID: 23152499
[TBL] [Abstract][Full Text] [Related]
11. A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach.
Yang F; Robotham JM; Grise H; Frausto S; Madan V; Zayas M; Bartenschlager R; Robinson M; Greenstein AE; Nag A; Logan TM; Bienkiewicz E; Tang H
PLoS Pathog; 2010 Sep; 6(9):e1001118. PubMed ID: 20886100
[TBL] [Abstract][Full Text] [Related]
12. The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin A complexes.
Hopkins S; Bobardt M; Chatterji U; Garcia-Rivera JA; Lim P; Gallay PA
Antimicrob Agents Chemother; 2012 Jul; 56(7):3888-97. PubMed ID: 22585215
[TBL] [Abstract][Full Text] [Related]
13. Cyclophilin A-independent recruitment of NS5A and NS5B into hepatitis C virus replication complexes.
Chatterji U; Bobardt MD; Lim P; Gallay PA
J Gen Virol; 2010 May; 91(Pt 5):1189-93. PubMed ID: 20107018
[TBL] [Abstract][Full Text] [Related]
14. Suppression of viral RNA binding and the assembly of infectious hepatitis C virus particles in vitro by cyclophilin inhibitors.
Nag A; Robotham JM; Tang H
J Virol; 2012 Dec; 86(23):12616-24. PubMed ID: 22973029
[TBL] [Abstract][Full Text] [Related]
15. Correlation between NS5A dimerization and hepatitis C virus replication.
Lim PJ; Chatterji U; Cordek D; Sharma SD; Garcia-Rivera JA; Cameron CE; Lin K; Targett-Adams P; Gallay PA
J Biol Chem; 2012 Aug; 287(36):30861-73. PubMed ID: 22801423
[TBL] [Abstract][Full Text] [Related]
16. Critical role of cyclophilin A and its prolyl-peptidyl isomerase activity in the structure and function of the hepatitis C virus replication complex.
Liu Z; Yang F; Robotham JM; Tang H
J Virol; 2009 Jul; 83(13):6554-65. PubMed ID: 19386705
[TBL] [Abstract][Full Text] [Related]
17. Overall Structural Model of NS5A Protein from Hepatitis C Virus and Modulation by Mutations Confering Resistance of Virus Replication to Cyclosporin A.
Badillo A; Receveur-Brechot V; Sarrazin S; Cantrelle FX; Delolme F; Fogeron ML; Molle J; Montserret R; Bockmann A; Bartenschlager R; Lohmann V; Lippens G; Ricard-Blum S; Hanoulle X; Penin F
Biochemistry; 2017 Jun; 56(24):3029-3048. PubMed ID: 28535337
[TBL] [Abstract][Full Text] [Related]
18. HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors.
Chatterji U; Lim P; Bobardt MD; Wieland S; Cordek DG; Vuagniaux G; Chisari F; Cameron CE; Targett-Adams P; Parkinson T; Gallay PA
J Hepatol; 2010 Jul; 53(1):50-6. PubMed ID: 20451281
[TBL] [Abstract][Full Text] [Related]
19. The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A.
Waller H; Chatterji U; Gallay P; Parkinson T; Targett-Adams P
J Virol Methods; 2010 May; 165(2):202-10. PubMed ID: 20132841
[TBL] [Abstract][Full Text] [Related]
20. HCV NS5A dimer interface residues regulate HCV replication by controlling its self-interaction, hyperphosphorylation, subcellular localization and interaction with cyclophilin A.
Shanmugam S; Nichols AK; Saravanabalaji D; Welsch C; Yi M
PLoS Pathog; 2018 Jul; 14(7):e1007177. PubMed ID: 30036383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
